Toward Elimination of Hepatitis B Virus Using Novel Drugs, Approaches, and Combined Modalities.
Toward Elimination of Hepatitis B Virus Using Novel Drugs, Approaches, and Combined Modalities.
复制标题
DOI:
10.1016/j.cld.2016.07.001
复制
发表时间:
2016-11
影响因子:
5.1
通讯作者:
Schinazi RF
中科院分区:
文献类型:
--
作者:
Boucle S;Bassit L;Ehteshami M;Schinazi RF
With nearly 30% of the world population infected, hepatitis B virus (HBV) causes significant morbidity and mortality worldwide. Although several potent antiviral agents are currently in use against HBV infection, the majority of chronically infected individuals do not achieve a functional and complete cure, as measured by the clearance of HB surface antigen (HBsAg) from blood and eradication of the covalently closed-circular DNA (cccDNA) from the nuclei of hepatocytes. In addition, even treated persons who achieve a long-term (> 10-15 years) sustained virological response (undetectable HBV DNA), are still at high risk of developing morbidity and mortality from liver complications. This review focuses upon novel, mechanistically diverse anti-HBV therapeutic strategies that are currently in development or in clinical evaluation, and highlights new combination strategies which may contribute to full elimination of HBV DNA and cccDNA from the infected liver, leading to a complete cure of chronic hepatitis B.
登录
查看更多内容
影响因子:
3.7
作者:
Rebbapragada, Indrani;Birkus, Gabriel;Pflanz, Stefan
通讯作者:
Pflanz, Stefan
DOI:
10.1038/mtna.2014.38
发表时间:
2014-08-19
期刊:
Molecular therapy. Nucleic acids
影响因子:
--
作者:
通讯作者:
--
影响因子:
4.3
作者:
Hai, Hoang;Tamori, Akihiro;Kawada, Norifumi
通讯作者:
Kawada, Norifumi
影响因子:
4.9
作者:
Cai, Dawei;Mills, Courtney;Guo, Haitao
通讯作者:
Guo, Haitao
影响因子:
5.4
作者:
Guo, Haitao;Jiang, Dong;Guo, Ju-Tao
通讯作者:
Guo, Ju-Tao